APOA1 and renal cell adenocarcinoma: The discrepancy of the results could be possibly due to the different set of cancers under investigation, as Hongjie et al. (2015) [20] studied the APOA1 levels in renal cell cancer, and their cut off values for APOA1 were quite high and different from our study.